Formetorex
![]() | |
| Names | |
|---|---|
| Preferred IUPAC name N-(1-Phenylpropan-2-yl)formamide | |
| Other names Formetorex N-Formylamphetamine N-(alpha-Methylphenethyl)formamide | |
| Identifiers | |
3D model (JSmol) | |
| 1563 | |
| ChEMBL | |
| ChemSpider | |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C10H13NO | |
| Molar mass | 163.220 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Formetorex (INN), also known as formetamide or N-formylamphetamine, is a substituted amphetamine described as an anorectic which does not appear to have ever been marketed.[1]
Formetorex is also an intermediate in the production of amphetamine by the "Leuckart reaction."[2] It is also commonly found as an impurity in clandestine labs where this synthesis method is used.[2][3] Due to the simplicity of the Leuckart reaction, it is the most popular synthetic route employed for the illicit manufacture of amphetamines.[2] The synthesis involves a non-metal reduction that is typically carried out in three steps.[2] For amphetamine synthesis, a mixture of phenylacetone and formamide (sometimes in the presence of formic acid) or ammonium formate, is heated until a condensation reaction results in the intermediate product, formetamide.[2] In the second step, formetamide is hydrolysed using hydrochloric acid, and the reaction mixture is then basified, isolated, and steam distilled to produce the free base.[2] The final step, the product is dissolved in an organic solvent and precipitated as the sulphate salt of amphetamine by adding sulfuric acid.[2]
It can in theory also serve as a precursor to methamphetamine, by removing the aldehyde group with a strong reducing agent such as LAH (in PiHKAL, Shulgin describes the analogous synthesis of MDMA by reduction of N-formyl-3,4-methylenedioxyamphetamine).
References
- ^ Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 568–. ISBN 978-0-412-46630-4.
- ^ a b c d e f g Laboratory and Scientific Section (2006). Recommended methods of the identification and analysis of amphetamine, methamphetamine, and their ring-substituted analogues in seized materials (PDF). New York: United Nations Office on Drugs and Crime Vienna. ISBN 92-1-148208-9. Retrieved 14 October 2013.
- ^ Kram TC (July 1979). "Reidentification of a major impurity in illicit amphetamine". Journal of Forensic Sciences. 24 (3): 596–9. doi:10.1520/JFS10875J. PMID 541629.
External links
- formetamide at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
| Stimulants |
| ||||||
|---|---|---|---|---|---|---|---|
| Cannabinoid antagonists | |||||||
| GLP-1, GIP, and / or glucagon agonists | |||||||
| DACRAs | |||||||
| 5-HT2C receptor agonists | |||||||
| Absorption inhibitors | |||||||
| Uncouplers | |||||||
| Others | |||||||
| |||||||
| Adamantanes | |
|---|---|
| Adenosine antagonists | |
| Alkylamines | |
| Ampakines | |
| Arylcyclohexylamines | |
| Benzazepines | |
| Cathinones |
|
| Cholinergics |
|
| Convulsants | |
| Eugeroics | |
| Oxazolines | |
| Phenethylamines |
|
| Phenylmorpholines | |
| Piperazines | |
| Piperidines |
|
| Pyrrolidines | |
| Racetams | |
| Tropanes |
|
| Tryptamines | |
| Others |
|
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) | |||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||
| |||||||||||||||||

